These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 24932150)

  • 21. Screening for adolescent depression: comparison of the Kutcher Adolescent Depression Scale with the Beck depression inventory.
    LeBlanc JC; Almudevar A; Brooks SJ; Kutcher S
    J Child Adolesc Psychopharmacol; 2002; 12(2):113-26. PubMed ID: 12188980
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Validity of Self-rating Screening Scales for the Diagnosis of Depression and Anxiety in Adult Patients With Bronchiectasis.
    Colomo N; Olveira C; Hernández-Pedrosa J; Bergero T; Fábrega-Ruz J; Porras N; Girón MV; de Rota LF; Olveira G
    Arch Bronconeumol (Engl Ed); 2021 Mar; 57(3):179-185. PubMed ID: 32143909
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Validation of the Russian version of neurological disorders depression inventory for epilepsy (NDDI-E).
    Zinchuk M; Kustov G; Pashnin E; Gersamia A; Rider F; Yakovlev A; Guekht A
    Epilepsy Behav; 2020 Dec; 113():107549. PubMed ID: 33246233
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Depression and anxiety among coronary heart disease patients: can affect dimensions and theory inform diagnostic disorder-based screening?
    Tully PJ; Penninx BW
    J Clin Psychol; 2012 Apr; 68(4):448-61. PubMed ID: 22308051
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The cut-off points of the Depression and Somatic Symptoms Scale and the Hospital Anxiety and Depression Scale in detecting non-full remission and a current major depressive episode.
    Hung CI; Liu CY; Wang SJ; Yao YC; Yang CH
    Int J Psychiatry Clin Pract; 2012 Mar; 16(1):33-40. PubMed ID: 22122659
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cognitive and anxiety symptoms in screening for clinical depression in diabetes: a systematic examination of diagnostic performances of the HADS and BDI-SF.
    Sultan S; Luminet O; Hartemann A
    J Affect Disord; 2010 Jun; 123(1-3):332-6. PubMed ID: 19861228
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validation of diagnostic tests for depressive disorder in drug-resistant mesial temporal lobe epilepsy.
    de Lemos Zingano B; Guarnieri R; Diaz AP; Schwarzbold ML; Bicalho MA; Claudino LS; Markowitsch HJ; Wolf P; Lin K; Walz R
    Epilepsy Behav; 2015 Sep; 50():61-6. PubMed ID: 26119622
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Validation of the emotion thermometers and hospital anxiety and depression scales in Singapore: Screening cancer patients for distress, anxiety and depression.
    Beck KR; Tan SM; Lum SS; Lim LE; Krishna LK
    Asia Pac J Clin Oncol; 2016 Jun; 12(2):e241-9. PubMed ID: 24673756
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Early detection of major depression in paediatric care: validity of the beck depression inventory-second edition (BDI-II) and the beck depression inventory-fast screen for medical patients (BDI-FS)].
    Pietsch K; Hoyler A; Frühe B; Kruse J; Schulte-Körne G; Allgaier AK
    Psychother Psychosom Med Psychol; 2012 Nov; 62(11):418-24. PubMed ID: 22723284
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of mental health screening tools for detecting antenatal depression and anxiety disorders in South African women.
    van Heyningen T; Honikman S; Tomlinson M; Field S; Myer L
    PLoS One; 2018; 13(4):e0193697. PubMed ID: 29668725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The accuracy of HADS and GHQ-12 in detecting psychiatric morbidity in breast cancer patients].
    Krespi Boothby MR; Hill J; Holcombe C; Clark L; Fisher J; Salmon P
    Turk Psikiyatri Derg; 2010; 21(1):49-59. PubMed ID: 20204904
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validation of the Generalized Anxiety Disorder-7 (GAD-7) in Russian people with epilepsy.
    Zinchuk M; Kustov G; Pashnin E; Gersamia A; Rider F; Yakovlev A; Voinova N; Popova S; Avedisova A; Guekht A
    Epilepsy Behav; 2021 Oct; 123():108269. PubMed ID: 34500434
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Validation of clinical symptom IRT scores for diagnosis and severity assessment of common mental disorders.
    Olariu E; Castro-Rodriguez JI; Álvarez P; Garnier C; Reinoso M; Martín-López LM; Alonso J; Forero CG
    Qual Life Res; 2015 Apr; 24(4):979-92. PubMed ID: 25281010
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Screening for depression in epilepsy clinics. A comparison of conventional and visual-analog methods.
    Rampling J; Mitchell AJ; Von Oertzen T; Docker J; Jackson J; Cock H; Agrawal N
    Epilepsia; 2012 Oct; 53(10):1713-21. PubMed ID: 22765759
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ultra-short screening instruments for major depressive episode and generalized anxiety disorder in epilepsy: The NDDIE-2 and the GAD-SI.
    Micoulaud-Franchi JA; Bartolomei F; McGonigal A
    J Affect Disord; 2017 Mar; 210():237-240. PubMed ID: 28064112
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reliability and validity of the Hospital Anxiety and Depression Scale and the Beck Depression Inventory (Full and FastScreen scales) in detecting depression in persons with hepatitis C.
    Golden J; Conroy RM; O'Dwyer AM
    J Affect Disord; 2007 Jun; 100(1-3):265-9. PubMed ID: 17156850
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Generalized Anxiety Disorder Screener (GAD-7) and the anxiety module of the Hospital and Depression Scale (HADS-A) as screening tools for generalized anxiety disorder among cancer patients.
    Esser P; Hartung TJ; Friedrich M; Johansen C; Wittchen HU; Faller H; Koch U; Härter M; Keller M; Schulz H; Wegscheider K; Weis J; Mehnert A
    Psychooncology; 2018 Jun; 27(6):1509-1516. PubMed ID: 29473255
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Test Performance Characteristics of the AIR, GAD-7, and HADS-Anxiety Screening Questionnaires for Anxiety in Chronic Obstructive Pulmonary Disease.
    Baker AM; Holbrook JT; Yohannes AM; Eakin MN; Sugar EA; Henderson RJ; Casper AS; Kaminsky DA; Rea AL; Mathews AM; Que LG; Ramsdell JW; Gerald LB; Wise RA; Hanania NA;
    Ann Am Thorac Soc; 2018 Aug; 15(8):926-934. PubMed ID: 29986152
    [No Abstract]   [Full Text] [Related]  

  • 39. Validation of depression screening scales in patients with CKD.
    Hedayati SS; Minhajuddin AT; Toto RD; Morris DW; Rush AJ
    Am J Kidney Dis; 2009 Sep; 54(3):433-9. PubMed ID: 19493600
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Depression and anxiety as predictors of 2-year cardiac events in patients with stable coronary artery disease.
    Frasure-Smith N; Lespérance F
    Arch Gen Psychiatry; 2008 Jan; 65(1):62-71. PubMed ID: 18180430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.